help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 29, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0009
This Article
Right arrow Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Pinar, H.
Right arrow Articles by Hauguel-de Mouzon, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinar, H.
Right arrow Articles by Hauguel-de Mouzon, S.
Related Collections
Right arrow Metabolism
Right arrow Pediatric Endocrinology

Submitted on January 3, 2008
Accepted on April 21, 2008

High molecular weight multimer complexes and vascular expression contribute to high adiponectin in the fetus

H. Pinar, S. Basu, K. Hotmire, L. Laffineuse, L. Presley, M. Carpenter, P. M. Catalano, and S. Hauguel-de Mouzon*

Women and Infant Hospital Rhode Island, Department Obstetrics and Gynecology, Brown University, Providence, RI

* To whom correspondence should be addressed. E-mail: shdemouzon{at}metrohealth.org.

Context: High plasma adiponectin concentrations in human fetuses and neonates are unique features of early developmental stages. Yet, the origins of the high adiponectin concentrations in the perinatal period remain elusive.

Objective: This study was undertaken to identify the sources and functional properties of adiponectin in utero.

Design and Methods: Tissue specimen were obtained at autopsy from 21–39 week old stillborn human fetuses. Adipose tissue and placenta were obtained at term elective C-section. Adiponectin complexes and expression were measured by immunodetection and realtime PCR.

Results: Adiponectin mRNA transcripts were detected in fetal subcutaneous and omental adipose depots at lower concentrations than in maternal adipose tissue. Immunoreactive adiponectin was also observed in vascular endothelial cells of fetal organs including skeletal muscle, kidney and brain. The absence of adiponectin in all placental cell types and lack of correlation between maternal and umbilical adiponectin indicate that umbilical adiponectin reflects its exclusive production by fetal tissues. The most prominent forms of adiponectin in fetal plasma were high (HMW) and low (LMW) molecular weight multimers of 340 and 160 kDa. The proportion of the HMW complexes was 5-fold (p<0.001) higher in umbilical plasma than in adult. The high HMW and total adiponectin levels were associated with lower insulin concentration and lower HOMA-IR indices in umbilical plasma, reflecting higher insulin sensitivity of the fetus compared to adult.

Conclusions: The abundance of HMW adiponectin and its vascular expression are characteristics of human fetal adiponectin. Combined with high insulin sensitivity, fetal adiponectin may be a critical determinant of in utero growth.


Key words: Adiponectin complexes • Adipose tissue • endothelial cells • Human • Fetus • Placenta







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society